PharmiWeb.com - Global Pharma News & Resources
24-Jun-2019

Next Generation Sequencing (NGS) With An Exponential CAGR Of 22.2% And Market Is Expected To Grow Significantly USD 17.44 Billion By 2024

Global next generation sequencing (NGS) market is expected to grow significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at an exponential CAGR of 22.2% from 2018 to 2024.

The global next generation sequencing (NGS) market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/11784

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global next generation sequencing (NGS) market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the global next generation sequencing (NGS) market?

What is the market drivers, restrains, opportunities governing the global next generation sequencing (NGS) market?

Which are the largest and the fastest growing segments in the global next generation sequencing (NGS) market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-next-generation-sequencing-market-emr-11784

Factors propelling the growth of next generation sequencing (NGS) market include technological advancements in data integration and cloud computing, growing demand for new scientific research, and strong demand for clinical diagnostic. Moreover, increasing adoption of next generation sequencing technology in various end-user segments and growing investments in research and development is further propelling the market growth.

The years used for the assessment are as follows;

Historical year: 2014, 2015, and 2016
Base year: 2017
Forecast period: 2018 ndash; 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, government websites, annual reports, press releases, white papers, surveys, investor presentation of companies, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total next generation sequencing market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global next generation sequencing market
Finalizing the overall size and share of the global next generation sequencing market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the global next generation sequencing market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the next generation sequencing market and provide their competitive landscape

MARKET SCOPE

The research scope for global next generation sequencing market is as follows:

By Product Type

Instruments
Reagents amp; consumables
Services

By Sequencing Type

Methyl Sequencing
Whole Genome Sequencing
CHIP Sequencing
Targeted Sequencing amp; Resequencing
RNA Based Targeted Sequencing
DNA Based Targeted Sequencing
De Novo Sequencing
Others

By Application

Diagnostics
Genetic Diagnostic
Pre-implantation Screening
Cancer Diagnostics
Prenatal Testing
Reproductive Health Diagnostics
Other

Drug Discovery
Personalized Medicine
Agriculture and Animal Research
Biomarker Discovery
Others

By End-User

Academic Institutes amp; Research Centers
Hospitals amp; Clinics
Pharmaceutical Companies
Biotech Companies

By Region

North America
Europe
Asia-Pacific
Central amp; South America
Middle East and Africa

FREE ANALYSIS

The ability of Next-generation sequencing (NGS) technology to generate large amount of sequence data in a short time helps in wide range of genetic analysis, and is being rapidly used in advance clinical research. The strong demand of NGS technology is mainly due to its growing applications in chromosome counting, molecular analysis, gene expression profiling, detection of epigenetic changes, and disease detection. NGS technology presents progressive advantages of cost effectiveness, high resolution and accuracy in genetic analysis. With the use of NGS technology, millions of changes in DNA can be detected with a single test and the cause of disease can be determined. Moreover, growing research and development activities in NGS has resulted in increased demand from various end-user segments.

Geographically, the global NGS market is segmented into North America, Europe, Asia-Pacific, Central amp; South America, and Middle East and Africa. North America held the major share of the global market in 2017. The growth in the region is attributed to the increasing investments in research and development activities due to the high prevalence of cancer and infectious diseases. Moreover, development in NGS bioinformatics solutions and pre-sequencing, and presence of major player in the region is also driving the market growth. North America is witnessing strong demand for various tests such as non-invasive prenatal test (NIPT), clinical laboratory-developed test (LDT), microbiology and infectious disease testing, which is expected to propel the market growth during the forecast period. Factors driving growth in the European NGS market are; emergence of new applications in various disease diagnosis and significant government support in the region. The NGS market in Asia-Pacific is witnessing significant growth, owing to growing research and development in NGS based diagnostics and genetic research. Moreover, the growing adoption of NGS technology in various end-user segments in Asia-Pacific countries such as Japan, India, and China for new drug and clinical developments is expected to fuel the market growth during 2018-2024.

Some of the key companies operating in the market include Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., GENEWIZ, Inc., PierianDx., Eurofins Genomics, 10x Genomics, Genomatix AG, QIAGEN, BGI Genomics Co., Ltd., Macrogen, Inc., Thermo Fisher Scientific, and among others.

Few Significant from Table Of Contents

Global Next Generation Sequencing Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope amp; assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Next Generation Sequencing (NGS)- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global next generation sequencing (NGS) market

3.4. Value chain analysis

3.5. Market opportunities amp; trends

3.5.1. Technological advancements in data integration and cloud computing

3.5.2. Emerging applications of NGS in food testing and personalized medicine

3.5.3. Market driver analysis

3.5.3.1. Strong demand for clinical diagnostic

3.5.3.2. Increasing adoption of NGS technology in various end-user segments

3.5.3.3. Increasing investments in research and development for genomic and proteomic sequence determination

3.5.3.4. Increasing usage of NGS in drug development

3.5.4. Market restraint analysis

3.5.4.1. Lack of skilled professionals

3.5.5. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Company share analysis

4.2. Competitive factors

4.3. Strategies adopted

CHAPTER 5. Global Next Generation Sequencing (NGS) Market Size and Forecast (2014 ndash; 2024)

5.1. Global Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

5.1.1. Instruments

5.1.2. Reagents amp; consumables

5.1.3. Services

5.2. Global Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

5.2.1. Methyl Sequencing

5.2.2. Whole Genome Sequencing

5.2.3. CHIP Sequencing

5.2.4. Targeted Sequencing amp; Resequencing

5.2.4.1. RNA Based Targeted Sequencing

5.2.4.2. DNA Based Targeted Sequencing

5.2.5. De Novo Sequencing

5.2.6. Others

5.3. Global Next Generation Sequencing (NGS) Market, By Application (USD Billion)

5.3.1. Diagnostics

5.3.1.1. Genetic Diagnostic

5.3.1.2. Pre-implantation Screening

5.3.1.3. Cancer Diagnostics

5.3.1.4. Prenatal Testing

5.3.1.5. Reproductive Health Diagnostics

5.3.1.6. Other

5.3.2. Drug Discovery

5.3.3. Personalized Medicine

5.3.4. Agriculture and Animal Research

5.3.5. Biomarker Discovery

5.3.6. Others

5.4. Global Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

5.4.1. Academic Institutes amp; Research Centers

5.4.2. Hospitals amp; Clinics

5.4.3. Pharmaceutical Companies

5.4.4. Biotech Companies

CHAPTER 6. Global Next Generation Sequencing (NGS) Market, By Geography

6.1. North America Next Generation Sequencing (NGS) Market

6.1.1. North America Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.1.2. North America Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.1.3. North America Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.1.4. North America Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.1.5. North America Next Generation Sequencing (NGS) Market, By Country

6.1.5.1. United States

6.1.5.2. Canada

6.1.5.3. Mexico

6.2. Europe Next Generation Sequencing (NGS) Market

6.2.1. Europe Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.2.2. Europe Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.2.3. Europe Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.2.4. Europe Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.2.5. Europe Next Generation Sequencing (NGS) Market, By Country

6.2.5.1. United Kingdom

6.2.5.2. France

6.2.5.3. Germany

6.2.5.4. Spain

6.2.5.5. Netherlands

6.2.5.6. Italy

6.2.5.7. Belgium

6.2.5.8. Sweden

6.2.5.9. Switzerland

6.2.5.10. Norway

6.2.5.11. Austria

6.2.5.12. Finland

6.2.5.13. Denmark

6.2.5.14. Iceland

6.2.5.15. Portugal

6.2.5.16. Russia

6.2.5.17. Rest of Europe

6.3. Asia-Pacific Next Generation Sequencing (NGS) Market

6.3.1. Asia-Pacific Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.3.2. Asia-Pacific Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.3.3. Asia-Pacific Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.3.4. Asia-Pacific Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.3.5. Asia-Pacific Next Generation Sequencing (NGS) Market, By Country

6.3.5.1. Japan

6.3.5.2. China

6.3.5.3. India

6.3.5.4. Singapore

6.3.5.5. Australia

6.3.5.6. New Zealand

6.3.5.7. Rest of Asia-Pacific

6.4. Central amp; South America Next Generation Sequencing (NGS) Market

6.4.1. Central amp; South America Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.4.2. Central amp; South America Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.4.3. Central amp; South America Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.4.4. Central amp; South America Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.4.5. Central amp; South America Next Generation Sequencing (NGS) Market, By Country

6.4.5.1. Brazil

6.4.5.2. Chile

6.4.5.3. Argentina

6.4.5.4. Rest of Central amp; South America

6.5. Middle East and Africa Next Generation Sequencing (NGS) Market

6.5.1. Middle East and Africa Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.5.2. Middle East and Africa Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.5.3. Middle East and Africa Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.5.4. Middle East and Africa Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.5.5. Middle East and Africa Next Generation Sequencing (NGS) Market, By Region

6.5.5.1. Saudi Arabia

6.5.5.2. United Arab Emirates

6.5.5.3. Qatar

6.5.5.4. South Africa

6.5.5.5. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Illumina, Inc.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Oxford Nanopore Technologies

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Pacific Biosciences of California, Inc

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Agilent Technologies, Inc.

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. GENEWIZ, Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. PierianDx.

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Eurofins Genomics

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. 10x Genomics

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Genomatix AG

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. QIAGEN

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. BGI Genomics Co., Ltd.

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

7.12. Macrogen, Inc

7.12.1. Business Overview

7.12.2. Product and Service Offering

7.12.3. Financial Overview

7.12.4. Strategic Developments

7.13. Thermo Fisher Scientific

7.13.1. Business Overview

7.13.2. Product and Service Offering

7.13.3. Financial Overview

7.13.4. Strategic Developments

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11784

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 24-Jun-2019